Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
EDIT
Stock Latest News
Company Announcements
Regulatory Disruptions at FDA Threaten Editas Medicine’s Gene-Editing Timelines and Commercial Prospects
3d ago
EDIT
Premium
The Fly
Editas Medicine upgraded to Buy from Hold at JonesResearch
4d ago
EDIT
Premium
The Fly
Editas Medicine reports Q4 EPS (6c), consensus (26c)
5d ago
EDIT
Premium
Pre-Earnings
EDIT Upcoming Earnings Report: What to Expect?
25d ago
EDIT
Premium
The Fly
Editas Medicine price target lowered to $3.50 from $12 at Chardan
4M ago
EDIT
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
4M ago
AZN
BMY
Premium
Ratings
Cautious Hold Rating on Editas Medicine Amid Promising Preclinical Results and Development Uncertainties
4M ago
EDIT
Premium
Company Announcements
Editas Medicine Reports Q3 2025 Progress and Financials
4M ago
EDIT
Premium
The Fly
Editas Medicine price target raised to $4.60 from $4 at Clear Street
4M ago
EDIT
Premium
The Fly
Editas Medicine reports Q3 EPS (28c), consensus (38c)
4M ago
EDIT
Premium
Pre-Earnings
Editas Medicine Inc. (EDIT) Q3 Earnings Cheat Sheet
4M ago
EDIT
Premium
The Fly
FDA to speed up gene editing therapy approvals, Bloomberg reports
4M ago
CRSP
EDIT
Premium
The Fly
Video: This stock is dragging down the in vivo gene editing therapy space
5M ago
MGX
BEAM
Premium
Company Announcements
Editas Medicine’s Long-Term Study on EDIT-301: A Potential Game-Changer for Hemoglobinopathies
5M ago
EDIT
Premium
The Fly
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
5M ago
MGX
CRSP
Premium
The Fly
Intellia Therapeutics price target lowered to $30 from $36 at BofA
5M ago
BEAM
CRBU
Premium
The Fly
Editas Medicine management to meet with Cantor
5M ago
EDIT
Premium
Company Announcements
Editas Medicine Unveils Promising Preclinical Data on EDIT-401
5M ago
8K
EDIT
Premium
The Fly
Editas Medicine reports in vivo preclinical PoC data for EDIT-401
5M ago
EDIT
Premium
The Fly
KalVista appoints Bilal Arif as COO, Linea Aspesi as CPO
5M ago
EDIT
KALV
Premium
The Fly
Private Markets: Dyna Robotics raises $120M from Nvidia, Amazon
6M ago
V
MA
Premium
The Fly
Editas Medicine price target raised to $4 from $3 at Wells Fargo
6M ago
EDIT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
